What is the recommended management plan for a patient with hip pain due to trochanteric bursitis, iliopsoas tendinitis, and femoroacetabular impingement (FAI)?

Management of Hip Pain with Trochanteric Bursitis, Iliopsoas Tendinitis, and Femoroacetabular Impingement

Begin with a structured non-pharmacological and pharmacological combination approach, starting with acetaminophen up to 4g/day, physical therapy focused on hip strengthening and range of motion, and weight reduction if BMI >25, escalating to NSAIDs at the lowest effective dose if inadequate response, with image-guided corticosteroid injections reserved for refractory cases, and surgical intervention (arthroscopic treatment of FAI with concurrent bursectomy/tendon release) considered only after 3-6 months of failed conservative management 1, 2, 3.

Initial Diagnostic Workup

Start with plain radiographs of the pelvis and hip as the mandatory first imaging study 2. When radiographs are negative, equivocal, or nondiagnostic and you suspect extra-articular soft tissue pathology (trochanteric bursitis, iliopsoas tendinitis), proceed to MRI hip without IV contrast or ultrasound 2. For suspected FAI with labral pathology, MR arthrography or CT arthrography is appropriate 2.

Critical diagnostic pitfall: Patients with iliopsoas impingement often see an average of 2.2 providers over 2.1 years before diagnosis 4. Look specifically for anterior groin pain with hip flexion, reduced hip flexion strength, and pain reproduced with passive hip flexion. Trochanteric bursitis presents with lateral hip pain preventing side-lying at night 5.

Staged Treatment Algorithm

Stage 1: Conservative Management (First 8-12 Weeks)

Non-pharmacological interventions (implement all simultaneously):

• Structured physical therapy with specific exercise descriptors: load magnitude, repetitions/sets, duration, time under tension, and rest intervals must be defined 6
• Patient education about the relationship between pain and hip structure
• Weight reduction if BMI >25 or overweight 1
• Assistive devices (walking stick) for severe symptoms 1

Pharmacological ladder (advance sequentially):

1. First-line: Acetaminophen up to 4g/day for mild-moderate pain 1, 3
2. Second-line: NSAIDs at lowest effective dose if inadequate response to acetaminophen. For patients with GI risk factors, use non-selective NSAIDs plus gastroprotective agent OR selective COX-2 inhibitor 1, 3
3. Third-line: Opioid analgesics only if NSAIDs contraindicated, ineffective, or poorly tolerated 1. However, avoid chronic opioid use for this condition 3

Stage 2: Injection Therapy (If 8-12 Week Conservative Trial Fails)

Image-guided corticosteroid injections are appropriate for symptoms unresponsive to analgesics and NSAIDs 1, 2. The injection serves both diagnostic and therapeutic purposes:

• Iliopsoas bursal injection: Diagnostic relief confirms iliopsoas impingement 4, 7
• Trochanteric bursal injection: Relieves lateral hip pain and confirms trochanteric bursitis 2
• Intra-articular hip injection: For FAI-related symptoms, combine corticosteroid with structured 12-week rehabilitation program 8

Evidence from high-quality study: In patients with symptomatic FAI receiving intra-articular injection plus structured exercise, 68% avoided surgery at 24 months, with 93% satisfaction in the non-operative cohort 8. Patients who failed this approach and progressed to surgery reported significantly worse pain within the first 4 weeks after injection—this is your predictor for surgical candidacy 8.

Do NOT use: Intra-articular hyaluronic acid injection (strong recommendation against for hip OA) 3

Stage 3: Surgical Intervention (After 3-6 Months Failed Conservative Management)

Surgical indications are met when:

• Persistent symptoms despite 3-6 months of structured conservative management
• Diagnostic injection provided temporary relief but symptoms recurred
• Radiographic confirmation of structural pathology (FAI morphology, prominent lesser trochanter)
• Significant functional limitation affecting quality of life

Surgical approach for combined pathology:

For FAI + Trochanteric Bursitis (7% prevalence in FAI patients, 5.3× more common in females, 2.5× more common in age >30) 9:

• Hip arthroscopy with labral repair and femoral/acetabular osteoplasty
• Concurrent arthroscopic bursectomy and iliotibial band lengthening 9
• Outcomes equivalent to isolated FAI surgery at 42-month follow-up 9

For FAI + Iliopsoas Tendinitis:

• Hip arthroscopy for FAI correction
• Concurrent endoscopic iliopsoas fractional lengthening 4, 10
• Mean surgical satisfaction 8.0/10, with 88% stating they would undergo procedure again 4
• If prominent lesser trochanter identified on MRI, add lesser trochanterplasty 11

For isolated trochanteric bursitis (non-snapping):

• Endoscopic trochanteric bursectomy through minimal longitudinal ITB incision 5
• Reserve ITB release only for frank external snapping hip 5

Age-Specific Considerations

Young adults with symptomatic hip pathology and dysplasia/deformity: Consider osteotomy and joint-preserving surgical procedures before arthroplasty 1. This is critical for long-term joint preservation and quality of life.

Older patients with radiographic evidence and refractory pain/disability: Total hip arthroplasty becomes the definitive option 1.

Common Clinical Pitfalls to Avoid

1. Delayed diagnosis: The average time from symptom onset to surgical management for iliopsoas impingement is 3.0 years 4. Maintain high clinical suspicion and use diagnostic injections early.

2. Treating in isolation: These conditions frequently coexist—7% of FAI patients have concurrent trochanteric bursitis 9. Address all pathology simultaneously during surgical intervention.

3. Inadequate conservative trial: The 2023 study showing 68% success with injection plus structured exercise demonstrates that proper non-operative management requires both components, not injection alone 8.

4. Ignoring structural factors: Lesser trochanter morphology must be evaluated in iliopsoas tendinitis 11. Acetabular morphology, femoral version, and acetabular version influence treatment planning 10.

5. Premature surgery: Patients reporting worse pain within 4 weeks post-injection are surgical candidates 8, but those with gradual improvement should continue conservative management for full 6 months.

Monitoring and Follow-up

Track patient-reported outcomes at 8 weeks, 4 months, 6 months, 12 months, and 24 months using validated tools (Hip Outcome Score, Modified Harris Hip Score, VAS for pain frequency/severity) 8. Significant improvement in range of motion and isometric strength should be observed by 8 weeks with proper conservative management 8.